Evidence map›Paper›PMID 32816722›Full record

ArticleAntimicrobial agents and chemotherapy2020

Longitudinal Surveillance and Combination Antimicrobial Susceptibility Testing of Multidrug-Resistant

Ijeoma N Okoliegbe, Karolin Hijazi, Kim Cooper, Corinne Ironside, Ian M Gould

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. TheMicrobiology spectrum · 2022
    Article
  2. Role of Efflux in Antibiotic Resistance ofFrontiers in microbiology · 2022
    Article
  3. Genes · 2021
    Review
  4. Therapeutic advances in respiratory disease
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ijeoma N OkoliegbeDepartment of Medical Microbiology, Aberdeen Royal Infirmary, Aberdeen, United Kingdom ijeoma.okoliegbe@nhs.scot.ORCID 0000-0002-7886-7064
Karolin HijaziInstitute of Dentistry, University of Aberdeen, Aberdeen, United Kingdom.ORCID 0000-0002-8589-2129
Kim CooperDepartment of Medical Microbiology, Aberdeen Royal Infirmary, Aberdeen, United Kingdom.
Corinne IronsideDepartment of Medical Microbiology, Aberdeen Royal Infirmary, Aberdeen, United Kingdom.
Ian M GouldDepartment of Medical Microbiology, Aberdeen Royal Infirmary, Aberdeen, United Kingdom.
Aberdeen Royal Infirmary · GBUniversity of Aberdeen · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AchromobacterAchromobacter denitrificansCystic FibrosisGram-Negative Bacterial InfectionsAnti-Bacterial AgentsHumansMicrobial Sensitivity TestsAnti-Bacterial AgentsAchromobacter spp.antimicrobial susceptibility testingA. xylosoxidanscystic fibrosisEtestsynergy testing

Identifiers

PMID32816722
PMCPMC7577167
OpenAlexW3048451673

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.